Wilfred can Zuilen net worth and biography

Wilfred can Zuilen Biography and Net Worth

Insider of Zimmer Biomet
Mr. van Zuilen will be responsible for the marketing, sales and distribution of products, services and solutions in the EMEA region. Prior to joining Zimmer Biomet, Mr. van Zuilen served as Regional Vice President, North Western Europe (United Kingdom, Ireland, Nordics and Benelux) at Medtronic. Prior to that, he led Medtronic's Restorative Therapies Group of businesses for EMEA and has also held regional leadership positions with Covidien, Novartis and Edwards Lifesciences.

Mr. van Zuilen holds a bachelor's degree in Business Economics from Erasmus University in Rotterdam.

What is Wilfred can Zuilen's net worth?

The estimated net worth of Wilfred can Zuilen is at least $269,024.00 as of July 5th, 2022. Mr. can Zuilen owns 2,240 shares of Zimmer Biomet stock worth more than $269,024 as of December 1st. This net worth evaluation does not reflect any other investments that Mr. can Zuilen may own. Learn More about Wilfred can Zuilen's net worth.

How do I contact Wilfred can Zuilen?

The corporate mailing address for Mr. can Zuilen and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected] Learn More on Wilfred can Zuilen's contact information.

Has Wilfred can Zuilen been buying or selling shares of Zimmer Biomet?

Wilfred can Zuilen has not been actively trading shares of Zimmer Biomet during the last quarter. Most recently, Zuilen Wilfred Van sold 531 shares of the business's stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $105.22, for a transaction totalling $55,871.82. Following the completion of the sale, the insider now directly owns 2,240 shares of the company's stock, valued at $235,692.80. Learn More on Wilfred can Zuilen's trading history.

Who are Zimmer Biomet's active insiders?

Zimmer Biomet's insider roster includes Wilfred can Zuilen (Insider), Bryan Hanson (CEO), Arthur Higgins (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.

Are insiders buying or selling shares of Zimmer Biomet?

During the last year, insiders at the medical equipment provider sold shares 3 times. They sold a total of 38,480 shares worth more than $4,690,587.35. The most recent insider tranaction occured on July, 5th when insider Zuilen Wilfred Van sold 531 shares worth more than $55,871.82. Insiders at Zimmer Biomet own 0.7 % of the company. Learn More about insider trades at Zimmer Biomet.

Information on this page was last updated on 7/5/2022.

Wilfred can Zuilen Insider Trading History at Zimmer Biomet

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2022Sell531$105.22$55,871.822,240View SEC Filing Icon  
See Full Table

Wilfred can Zuilen Buying and Selling Activity at Zimmer Biomet

This chart shows Zuilen Wilfred Van's buying and selling at Zimmer Biomet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zimmer Biomet Company Overview

Zimmer Biomet logo
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Read More

Today's Range

Now: $121.89
Low: $120.15
High: $122.99

50 Day Range

MA: $110.46
Low: $104.55
High: $119.21

2 Week Range

Now: $121.89
Low: $100.39
High: $135.05


38,047 shs

Average Volume

1,108,616 shs

Market Capitalization

$25.58 billion

P/E Ratio


Dividend Yield